MedTrace Logo

Conjugated Linoleic Acid on Body Weight and Body Fat Mass for 12 Weeks

NCT04531137 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2021-08-17

No results posted yet for this study

Summary

This study has purpose to assess the effect of conjugated linoleic acid (CLA)-fortified milk powder with nutrition counseling and nutrition module in body weight and body fat mass among overweight and obese adult in Indonesia

Conditions

  • Overweight and Obesity
  • Body Weight

Interventions

DIETARY_SUPPLEMENT

CLA-fortified milk powder

3.4 gram of CLA-fortified milk powder one a day for 12 weeks

OTHER

Placebo

Placebo milk powder one a day for 12 weeks

OTHER

Nutrition Counseling

Individualized nutrition counseling using nutrition module at week 0, 4, and 8 for 30-45 minutes each session

Sponsors & Collaborators

  • BASF

    collaborator INDUSTRY

  • Indonesia University

    lead OTHER

Principal Investigators

  • Fiastuti Witjaksono, Doctoral · Department of Nutrition, Faculty of Medicine of Universitas Indonesia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-05
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04531137 on ClinicalTrials.gov